Global  

First human trial of Oxford Covid-19 vaccine shows promise

WorldNews Monday, 20 July 2020 ()
First human trial of Oxford Covid-19 vaccine shows promiseLondon - An experimental coronavirus vaccine being developed by AstraZeneca and Oxford university was safe and produced an immune response in early-stage clinical trials, data showed on Monday, keeping alive the hope it could be in use by the end of the year. The vaccine, called AZD1222, has been described by the World Health Organization's chief scientist as the leading candidate in a global race to halt a pandemic that has...
0
shares
ShareTweetSavePostSend
 
Video Credit: Al Jazeera STUDIO - Published
News video: UK coronavirus vaccine shows early promise

UK coronavirus vaccine shows early promise 10:06

Oxford University scientists say experimental vaccine prompts a protective immune response in its first human trial.

You Might Like


πŸ’‘ One News Page Knowledge: Other News Mentions

London London Capital of the United Kingdom

London's mayor proposes key workers get priority for cheaper housing

Sadiq Khan launches a consultation asking which occupations could be prioritised for cheaper homes.
BBC News

β€˜Don’t we owe these children a duty of care?’

The London grandmother who wants her grandchildren to return from Kurdish-run camps in Syria.
BBC News

Woman claims she saw Prince Andrew with Ghislaine Maxwell and Virginia Giuffre on 'Woking Pizza Express' night

She alleges she saw them at London nightclub Tramp, US lawyer says
Independent

Alexander Kareem death: Seven arrested in case of 'mistaken identity' murder

Seven people have been arrested on suspicion of the murder of Alexander Kareem, who was shot dead in Shepherd's Bush in west London in a suspected case of..
Independent
Drag queen embraces disability [Video]

Drag queen embraces disability

A maths tutor who lost his leg after being hit by a car has revealed how hisdrag queen alter ego has helped him embrace his disability. Ian Lilley, 43,had just moved from his home town in South Wales to London after landing aplace at prestigious drama school Mountview Academy in 2000 when his lifechanged forever. While unloading his possessions from a removal van as hemoved into his new flat, the driver of a passing car blacked out at the wheeland hit him. Airlifted to hospital, Ian came to hours later to find that hisleft leg, which had been smashed into 13 pieces, had been amputated. Foryears, Ian, now a science and maths tutor from Crouch End, north London, hidaway, desperately self-conscious. But now, he has unveiled his drag alter ego,Eileen Eiffell – which sounds like, β€˜I lean, I fall', a tongue-in-cheekreference to what he has been through – and he wants to help empower otherdisabled performers.

Credit: PA - Press Association STUDIO    Duration: 01:00Published

AstraZeneca British-Swedish pharmaceutical company

Europe Inc. plunges into the red [Video]

Europe Inc. plunges into the red

A huge day for earnings Thursday saw bleak numbers for European corporate titans including Renault, Volkswagen and Airbus. But drugmaker AstraZeneca sounded a more positive note. Julian Satterthwaite reports.

Credit: Reuters Studio    Duration: 01:37Published

DBT readies five sites for final phase of human trials of Oxford Covid vaccine: Secretary

Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca Covid-19 vaccine, Department of Biotechnology..
IndiaTimes
Sanofi eyes vaccine approval by early 2021 [Video]

Sanofi eyes vaccine approval by early 2021

French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports.

Credit: Reuters Studio    Duration: 01:13Published
AstraZeneca shares down after report it approached Gilead [Video]

AstraZeneca shares down after report it approached Gilead

Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:09Published

Oxford University Police Oxford University Police

COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR [Video]

COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites. Earlier, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford vaccine.

Credit: ANI    Duration: 02:24Published

Serum gets DCGI nod for Phase 2 & 3 trials

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage β€” Phase 2 and 3 β€” human trials in India for the Oxford..
IndiaTimes
COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again [Video]

COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again

The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford University. According to the World Health Organization (WHO), a number of vaccines are now in phase-3 clinical trials. Meanwhile, Chief Minister of Madhya Pradesh Shivraj Singh Chouhan on August 03 again tested positive for COVID-19 on the 10th day of his admission to hospital. Today, Andhra Pradesh reported 7,822 new COVID-19 cases, taking the total number of coronavirus cases in the state 1,66,586. Uttar Pradesh reported 4,473 new COVID-19 cases and 50 deaths in the last 24 hours, taking active cases to 40,191 and death toll to 1,778. Tamil Nadu reported 5,609 new COVID-19 cases and 109 deaths in the last 24 hours, taking total cases to 2,63,222 including 2,02,283 discharges and 4,241 deaths.

Credit: ANI    Duration: 01:38Published

DCGI nod to Serum Institute of India for phase 2 & 3 clinical trials of Oxford Covid-19 vaccine

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of the Oxford..
IndiaTimes

Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate

A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for..
IndiaTimes

World Health Organization World Health Organization Specialized agency of the United Nations

Coronavirus did come from bats, say WHO scientists sent to Wuhan

The coronavirus outbreak came from bats and was probably passed to humans through another intermediary animal "host", World Health Organisation (WHO) scientists..
WorldNews
WHO Warns There May Never Be A 'Silver Bullet' for COVID-19 [Video]

WHO Warns There May Never Be A 'Silver Bullet' for COVID-19

The World Health Organisation has warned that despite the progress in vaccine research, the road to normality remains far off.

Credit: Cover Video STUDIO    Duration: 00:55Published

6 months after declaring the coronavirus a global health emergency, WHO director says there may ...

Fabrice Coffrini / AFP / Getty World Health Organization's director-general on Monday warned that there may never be a "silver bullet" for the coronavirus...
WorldNews

Related videos from verified sources

Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR [Video]

Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR

At present country has three Indian COVID-19 vaccines which are in different phases of clinical testing, said Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava on Tuesday...

Credit: HT Digital Content     Duration: 06:42Published
What You Need to Know About Volunteering for a COVID-19 Vaccine Trial [Video]

What You Need to Know About Volunteering for a COVID-19 Vaccine Trial

Researchers are hard at work trying to develop a working vaccine for the coronavirus. But these vaccines aren’t made in a vacuum: they have to be tested out on human subjects.

Credit: Veuer     Duration: 00:59Published
Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity [Video]

Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity

The health ministry in its briefing on Covid-19 situation said that over 1 million people have recovered from Covid infection in the country. Addressing the media, Secretary in the Health Ministry..

Credit: HT Digital Content     Duration: 08:50Published

Related news from verified sources

Apple tech is being used to track the speed of U.S. reopening

Apple technologies and data are being used to track the reopening of the U.S. economy amid the global coronavirus health crisis. Credit: Apple For example,...
AppleInsider

Why coronavirus lockdowns are melting cocoa prices

Some analysts see chocolate demand as a good guide to the health of the global economy
FT.com Also reported by •BBC NewsProactive InvestorsWorldNews

China Uses W.H.O. Inquiry to Tout Coronavirus Response

The global health agency sent two experts to China, but it is unclear how much access they are getting. They must first complete a two-week quarantine.
NYTimes.com Also reported by •Proactive InvestorsSeattlePI.comThe Age

Tweets about this